Showing 1 - 20 results of 45,079 for search '(( 50 ((nn decrease) OR (_ decrease)) ) OR ((( _ linear decrease ) OR ( 5 w decrease ))))*', query time: 0.88s Refine Results
  1. 1
  2. 2
  3. 3
  4. 4

    Factors associated with decreased FVC by multiple linear regression analysis. by Eun Kyung Jang (732099)

    Published 2015
    “…<p>R<sup>2</sup> =. 39</p><p>Factors associated with decreased FVC by multiple linear regression analysis.…”
  5. 5

    Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s. by Djaloul Karboua (16510091)

    Published 2023
    “…<p>Scenario (6): Parameter variation (50% decrease)—With 5 N.m load applied at t = 0.3s.…”
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12

    Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

    Published 2014
    “…A small and a high reward intensity are shown. Reward rate decreases hyperbolically with price, eventually asymptoting. …”
  13. 13
  14. 14
  15. 15
  16. 16

    The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin... by Chanel Avenant (409756)

    Published 2025
    “…We measured testosterone by UHPLC-MS/MS and SHBG by immunoassay in matched pairs of serum samples collected at baseline (D0) and at peak serum progestin levels at 25 weeks post initiation (25W) (n = 214–218 pairs). Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …”
  17. 17

    Multiple C–H Activations of Linear Alkanes by Various (η<sup>5</sup>‑Cyclopentadienyl)W(NO)(CH<sub>2</sub>CMe<sub>3</sub>)<sub>2</sub> Complexes by Monica V. Shree (4092343)

    Published 2017
    “…As illustrated in the accompanying diagram, thermolysis of Cp*W­(NO)­(CH<sub>2</sub>CMe<sub>3</sub>)<sub>2</sub> (Cp* = η<sup>5</sup>-C<sub>5</sub>Me<sub>5</sub>) at 80 °C in neat linear alkanes effects three successive C–H bond activations of the hydrocarbon substrates and forms Cp*W­(NO)­(H)­(η<sup>3</sup>-allyl) complexes in which the allyl ligands are derived from the alkanes. …”
  18. 18
  19. 19
  20. 20